22 Einträge gefunden

1. Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV

   1. Kalmanti, Lida
   2. Saussele, Susanne
   3. Lauseker, Michael
   4. Proetel, Ulrike
   5. Müller, Martin C
   6. Hanfstein, Benjamin
   7. Schreiber, Annette

   2014 - Forschungsinformationssystem des UKE
2. Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV

   1. Hehlmann, Rüdiger
   2. Müller, Martin C
   3. Lauseker, Michael
   4. Hanfstein, Benjamin
   5. Fabarius, Alice
   6. Schreiber, Annette
   7. Proetel, Ulrike

   2014 - Forschungsinformationssystem des UKE
3. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

   1. Fu, Yuewen
   2. Schroeder, Thomas
   3. Zabelina, Tatiana
   4. Badbaran, Anita
   5. Bacher, Ulrike
   6. Kobbe, Guido
   7. Ayuketang, Francis Ayuk

   2014 - Forschungsinformationssystem des UKE
4. Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.

   1. Haferlach, Torsten
   2. Bacher, Ulrike
   3. Alpermann, Tamara
   4. Haferlach, Claudia
   5. Kern, Wolfgang
   6. Schnittger, Susanne

   2012 - Forschungsinformationssystem des UKE
5. Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Eder, Christiane
   4. Dicker, Frank
   5. Alpermann, Tamara
   6. Grossmann, Vera
   7. Kohlmann, Alexander

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
6. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.

   1. Kern, Wolfgang
   2. Bacher, Ulrike
   3. Haferlach, Claudia
   4. Dicker, Frank
   5. Alpermann, Tamara
   6. Schnittger, Susanne
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
7. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.

   1. Haferlach, Claudia
   2. Bacher, Ulrike
   3. Schnittger, Susanne
   4. Alpermann, Tamara
   5. Zenger, Melanie
   6. Kern, Wolfgang
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
8. Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity.

   1. Bacher, Ulrike
   2. Schnittger, Susanne
   3. Macijewski, Katja
   4. Grossmann, Vera
   5. Kohlmann, Alexander
   6. Alpermann, Tamara
   7. Kowarsch, Andreas

   2012 - Forschungsinformationssystem des UKE
9. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.

   1. Bacher, Ulrike
   2. Weissmann, Sandra
   3. Kohlmann, Alexander
   4. Schindela, Sonja
   5. Alpermann, Tamara
   6. Schnittger, Susanne
   7. Kern, Wolfgang

   2012 - Forschungsinformationssystem des UKE
10. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Haferlach, Torsten
    4. Wendland, Nicole
    5. Ulke, Madlen
    6. Dicker, Frank
    7. Grossmann, Vera

    2012 - Forschungsinformationssystem des UKE
11. Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course.

    1. Bacher, Ulrike
    2. Kern, Wolfgang
    3. Alpermann, Tamara
    4. Schnittger, Susanne
    5. Haferlach, Claudia
    6. Haferlach, Torsten

    2012 - Forschungsinformationssystem des UKE
12. Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemia.

    1. Kern, Wolfgang
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Alpermann, Tamara
    5. Dicker, Frank
    6. Schnittger, Susanne
    7. Haferlach, Torsten

    2012 - Forschungsinformationssystem des UKE
13. Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Alpermann, Tamara
    4. Reiter, Andreas
    5. Ulke, Madlen
    6. Dicker, Frank
    7. Eder, Christiane

    2012 - Forschungsinformationssystem des UKE - frei zugänglich
14. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Alpermann, Tamara
    4. Zenger, Melanie
    5. Hochhaus, Andreas
    6. Beelen, Dietrich W
    7. Uppenkamp, Michael

    2011 - Forschungsinformationssystem des UKE
15. Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Alpermann, Tamara
    4. Kern, Wolfgang
    5. Schnittger, Susanne
    6. Haferlach, Claudia

    2011 - Forschungsinformationssystem des UKE
16. Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Kern, Wolfgang
    5. Alpermann, Tamara
    6. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
17. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Schnittger, Susanne
    4. Kreipe, Hans
    5. Kröger, Nicolaus

    2011 - Forschungsinformationssystem des UKE
18. Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Fehse, Boris
    4. Schnittger, Susanne
    5. Kröger, Nicolaus

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
19. Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemia.

    1. Oyekunle, Anthony
    2. Haferlach, Torsten
    3. Kröger, Nicolaus
    4. Klyuchnikov, Evgeny
    5. Zander, Axel R.
    6. Schnittger, Susanne
    7. Bacher, Ulrike

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
20. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.

    1. Bacher, Ulrike
    2. Haferlach, Claudia
    3. Alpermann, Tamara
    4. Kern, Wolfgang
    5. Schnittger, Susanne
    6. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE - frei zugänglich